【レポートの概要（一部）】
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Prostate Cancer Market, By Type
5.1 Introduction
5.2 Hormone Sensitive
5.3 Hormone Refractory
6 Global Prostate Cancer Market, By Therapy
6.1 Introduction
6.2 Focal Therapies
6.3 Biologic Therapy
6.4 Cryosurgery
6.5 Immunotherapy
6.5.1 Vaccines
6.6 Therapeutic Vaccines
6.6.1 Provenge (Sipuleucel-T)
6.7 Radiation Therapy
6.7.1 External Beam
6.7.1.1 Stereotactic Body
6.7.1.2 Proton Beam
6.7.1.3 Intensity Modulated
6.7.1.4 3D Conformal
6.7.2 Brachytherapy
6.7.2.1 Temporary
6.7.2.2 Permanent
6.8 Chemotherapy
6.8.1 Vinorelbine
6.8.2 Vinblastine
6.8.3 Taxotere (Docetaxel)
6.8.4 Taxanes
6.8.5 Jevtana (Cabazitaxel)
6.8.6 Etoposide
6.8.7 Cytotoxic Drugs
6.8.8 Carboplatin
6.8.9 Antimetabolites
6.8.10 Anthracyclines
6.8.11 Alkylating Agents
6.9 Surgery
6.9.1 Trans Urethral Resection (TUR)
6.9.2 Radical Prostatectomy
6.9.3 Orchidectomy
6.10 Targeted Therapy
6.10.1 Tyrosine Kinase Inhibitors
6.10.2 Signal Transduction Inhibitor
6.10.3 Monoclonal Antibodies
6.10.4 Apoptosis Inducing Drugs
6.10.5 Angiogenesis Inhibitor
6.11 Bone Metastasis
6.11.1 Zometa (Zoledronic Acid)
6.11.2 Xofigo (Radium 223 Dichloride)
6.11.3 Xgeva (Denosumab)
6.11.4 Alpharadin
6.12 Hormonal Therapy
6.12.1 Aromatase Inhibitors
6.12.2 Estrogen-Receptor Modulators (Serms)
6.12.3 Luteinizing Hormone–Releasing Hormone (LHRH) Analogs
6.12.3.1 Lupron
6.12.3.2 Zoladex
6.12.3.3 Decapeptyl
6.12.3.4 Eligard
6.12.3.5 Vantas
6.12.3.6 Leuplin
6.12.3.7 Trelstar (Triptorelin Pamoate)
6.12.3.8 Firmagon (Degarelix)
6.12.3.9 Casodex (Bicalutamide)
6.12.4 Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists
6.12.4.1 Zytiga
6.12.4.2 Gonax
6.12.4.3 Xtandi (Enzalutamide)
6.12.5 Anti–Androgens
6.12.5.1 Casodex
6.12.5.2 Xtandi or MDV3100
6.12.5.3 Xtandi US or MDV3100
6.12.6 Other Hormonal Therapies
7 Global Prostate Cancer Market, By Diagnostic Technique
7.1 Introduction
7.2 Prostate Specific Antigen Test (PSA)
7.3 Digital Rectal Exam (DRE)
8 Global Prostate Cancer Market, By End User
8.1 Introduction
8.2 Ambulatory Surgical Centers
8.3 Hospitals
8.4 Pharmacies
8.5 Specialty Clinics
8.6 Other End Users
9 Global Prostate Cancer Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Astellas, Inc.
11.2 AstraZeneca plc
11.3 Bristol Myers Squibb (BMS)
11.4 Johnson & Johnson
11.5 NOVARTIS
11.6 Sanofi S.A
11.7 TOLMAR Inc.
11.8 Tokai Pharmaceuticals
11.9 Progenics Pharmaceuticals Inc.
11.10 OncoGenex Pharmaceuticals Inc.
11.11 OncBioMune Pharmaceuticals Inc.
11.12 Endo Pharmaceuticals
11.13 Bayer Pharma AG
List of Tables
Table 1 Global Prostate Cancer Market Outlook, By Region (2016-2026) (US $MN)
Table 2 Global Prostate Cancer Market Outlook, By Type (2016-2026) (US $MN)
Table 3 Global Prostate Cancer Market Outlook, By Hormone Sensitive (2016-2026) (US $MN)
Table 4 Global Prostate Cancer Market Outlook, By Hormone Refractory (2016-2026) (US $MN)
Table 5 Global Prostate Cancer Market Outlook, By Therapy (2016-2026) (US $MN)
Table 6 Global Prostate Cancer Market Outlook, By Focal Therapies (2016-2026) (US $MN)
Table 7 Global Prostate Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
Table 8 Global Prostate Cancer Market Outlook, By Cryosurgery (2016-2026) (US $MN)
Table 9 Global Prostate Cancer Market Outlook, By Immunotherapy (2016-2026) (US $MN)
Table 10 Global Prostate Cancer Market Outlook, By Vaccines (2016-2026) (US $MN)
Table 11 Global Prostate Cancer Market Outlook, By Therapeutic Vaccines (2016-2026) (US $MN)
Table 12 Global Prostate Cancer Market Outlook, By Provenge (Sipuleucel-T) (2016-2026) (US $MN)
Table 13 Global Prostate Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
Table 14 Global Prostate Cancer Market Outlook, By External Beam (2016-2026) (US $MN)
Table 15 Global Prostate Cancer Market Outlook, By Brachytherapy (2016-2026) (US $MN)
Table 16 Global Prostate Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
Table 17 Global Prostate Cancer Market Outlook, By Vinorelbine (2016-2026) (US $MN)
Table 18 Global Prostate Cancer Market Outlook, By Vinblastine (2016-2026) (US $MN)
Table 19 Global Prostate Cancer Market Outlook, By Taxotere (Docetaxel) (2016-2026) (US $MN)
Table 20 Global Prostate Cancer Market Outlook, By Taxanes (2016-2026) (US $MN)
Table 21 Global Prostate Cancer Market Outlook, By Jevtana (Cabazitaxel) (2016-2026) (US $MN)
Table 22 Global Prostate Cancer Market Outlook, By Etoposide (2016-2026) (US $MN)
Table 23 Global Prostate Cancer Market Outlook, By Cytotoxic Drugs (2016-2026) (US $MN)
Table 24 Global Prostate Cancer Market Outlook, By Carboplatin (2016-2026) (US $MN)
Table 25 Global Prostate Cancer Market Outlook, By Antimetabolites (2016-2026) (US $MN)
Table 26 Global Prostate Cancer Market Outlook, By Anthracyclines (2016-2026) (US $MN)
Table 27 Global Prostate Cancer Market Outlook, By Alkylating Agents (2016-2026) (US $MN)
Table 28 Global Prostate Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
Table 29 Global Prostate Cancer Market Outlook, By Trans Urethral Resection (TUR) (2016-2026) (US $MN)
Table 30 Global Prostate Cancer Market Outlook, By Radical Prostatectomy (2016-2026) (US $MN)
Table 31 Global Prostate Cancer Market Outlook, By Orchidectomy (2016-2026) (US $MN)
Table 32 Global Prostate Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
Table 33 Global Prostate Cancer Market Outlook, By Tyrosine Kinase Inhibitors (2016-2026) (US $MN)
Table 34 Global Prostate Cancer Market Outlook, By Signal Transduction Inhibitor (2016-2026) (US $MN)
Table 35 Global Prostate Cancer Market Outlook, By Monoclonal Antibodies (2016-2026) (US $MN)
Table 36 Global Prostate Cancer Market Outlook, By Apoptosis Inducing Drugs (2016-2026) (US $MN)
Table 37 Global Prostate Cancer Market Outlook, By Angiogenesis Inhibitor (2016-2026) (US $MN)
Table 38 Global Prostate Cancer Market Outlook, By Bone Metastasis (2016-2026) (US $MN)
Table 39 Global Prostate Cancer Market Outlook, By Zometa (Zoledronic Acid) (2016-2026) (US $MN)
Table 40 Global Prostate Cancer Market Outlook, By Xofigo (Radium 223 Dichloride) (2016-2026) (US $MN)
Table 41 Global Prostate Cancer Market Outlook, By Xgeva (Denosumab) (2016-2026) (US $MN)
Table 42 Global Prostate Cancer Market Outlook, By Alpharadin (2016-2026) (US $MN)
Table 43 Global Prostate Cancer Market Outlook, By Hormonal Therapy (2016-2026) (US $MN)
Table 44 Global Prostate Cancer Market Outlook, By Aromatase Inhibitors (2016-2026) (US $MN)
Table 45 Global Prostate Cancer Market Outlook, By Estrogen-Receptor Modulators (Serms) (2016-2026) (US $MN)
Table 46 Global Prostate Cancer Market Outlook, By Luteinizing Hormone–Releasing Hormone (LHRH) Analogs (2016-2026) (US $MN)
Table 47 Global Prostate Cancer Market Outlook, By Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists (2016-2026) (US $MN)
Table 48 Global Prostate Cancer Market Outlook, By Anti–Androgens (2016-2026) (US $MN)
Table 49 Global Prostate Cancer Market Outlook, By Other Hormonal Therapies (2016-2026) (US $MN)
Table 50 Global Prostate Cancer Market Outlook, By Diagnostic Technique (2016-2026) (US $MN)
Table 51 Global Prostate Cancer Market Outlook, By Prostate Specific Antigen Test (PSA) (2016-2026) (US $MN)
Table 52 Global Prostate Cancer Market Outlook, By Digital Rectal Exam (DRE) (2016-2026) (US $MN)
Table 53 Global Prostate Cancer Market Outlook, By End User (2016-2026) (US $MN)
Table 54 Global Prostate Cancer Market Outlook, By Ambulatory Surgical Centers (2016-2026) (US $MN)
Table 55 Global Prostate Cancer Market Outlook, By Hospitals (2016-2026) (US $MN)
Table 56 Global Prostate Cancer Market Outlook, By Pharmacies (2016-2026) (US $MN)
Table 57 Global Prostate Cancer Market Outlook, By Specialty Clinics (2016-2026) (US $MN)
Table 58 Global Prostate Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)
NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.
【レポート販売概要】
■ タイトル：前立腺がんの世界市場展望2017-20276■ 英文：Prostate Cancer - Global Market Outlook (2017-2026)
■ 発行日：2019年8月
■ 調査会社：Stratistics MRC
■ 商品コード：SMRC20FB306
■ 調査対象地域：グローバル
- 石炭火力発電のグローバル市場（2014-2018）About Coal-fired Power Generation Coal-fired power generation is the technique of generating electricity through combustion of coal. This is one of the oldest techniques of generating electricity. The large untapped coal reserve is one of the major factors boosting the growth of the Global Coal-fired Power Generation market. Increasing demand for electricity from various end-users has pushed the p …
- 止血帯システムの世界市場分析：コンポーネント別（止血帯用具、止血帯カフス[空気圧{使い捨て、再利用}、非空気圧]）、用途別、セグメント予測、2014-2025The global tourniquet systems market is expected to reach USD 594.8 million by 2025, according to a new report by Grand View Research, Inc. Growing incidence of industrial & road accidents and major falls has been a major factor driving market growth. In addition, rapid increase in the number of hospitals and surgical care centers has led to increased application of tourniquets.Tourniquets are maj …
- 自動車用半導体の世界市場2015-2019About Automotive Semiconductors Automobiles today comprise mechanical and electronic systems, and use microprocessors extensively. The evolution of semiconductor technology has enabled automobile manufacturers to optimize performance by multiplying the applications of a chip. Safety systems, driver assistance, powertrain control, communications, and infotainment systems use automotive electronics. …
- 世界の流体処理市場動向（2012-2016）TechNavio’s analysts forecast the Global Fluid Treatment market to reach US$259.77 billion by 2016. One of the key factors contributing to this market growth is the increasing demand from developing countries. The Global Fluid Treatment market has also been witnessing an increasing number of mergers and acquisitions. However, the increasing price war among the competitors could pose a challenge to …
- ブラジル/ロシア/インド/中国の糖尿病治療デバイス市場：セルフモニタリング血糖値計、連続血糖モニター、試験ストリップ、ランセット、インスリンポンプ、インスリンペン、インスリン注射器Diabetes is a group of metabolic disorders, characterized by high blood glucose levels due to either inadequate insulin production or insulin resistance. Diabetes care devices are used to manage blood glucose levels. There are mainly two types of diabetes care devices, namely, blood glucose monitoring devices and insulin delivery devices. The BRIC diabetes care devices market is largely driven by …
- 糖尿病の微小血管合併症：企業と競争環境PharmaPoint: Microvascular Complications of Diabetes - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Microvascular Complications of Diabetes - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Microvascular Complications of Diabetes Market. The report ident …
- 軍事用インフラ及び物流サービスの世界市場About Military Infrastructure and Logistics Military Infrastructure and Logistics services are an essential element for the optimum functioning of the armed forces. The construction of modern military facilities with proper secure communication channels and technological integration is in demand today. Timely delivery and adequate supply of essential elements such as ammunition, ration supplies, v …
- ペラルゴン酸の世界市場Pelargonic Acid (n-Nonanoic acid ) (CAS 112-05-0) Market Research Report 2014 presents comprehensive data on pelargonic acid (n-nonanoic acid) markets globally and regionally (Europe, Asia, North America etc.) The report includes pelargonic acid (n-nonanoic acid) description, covers its application areas and related patterns. It overviews pelargonic acid (n-nonanoic acid) market, names pelargonic …
- 高性能計算（HPC）の世界市場：サーバ、ストレージ、ネットワークデバイス、ソフトウェアThe High Performance Computing (HPC) market is estimated to grow from USD 28.08 Billion in 2015 and projected to be of USD 36.62 Billion by 2020, at a high Compound Annual Growth Rate (CAGR) of 5.45% during the forecast period. The scalability of applications, higher processing power, and faster storage solutions is driving the growth of the HPC market. The growth in supercomputing clusters and sc …
- 世界の繊維化学薬品市場（2014-2018）TechNavio's analysts forecast the Global Textile Chemicals market to grow at a CAGR of 3.60 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased demand for finishing chemicals. The Global Textile Chemicals market has also been witnessing the development of eco-friendly products and bio-auxiliaries. However, the rising environmental concerns …
- リテールクラウドの世界市場予測（～2021年）Rapid adoption of smartphones, need for compliance & collaboration, and shift to omni-channel experience are expected to drive the overall retail cloud marketThe retail cloud market size is estimated to grow from USD 11.06 billion in 2016 to USD 28.53 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 20.9% due to factors such as rapid adoption of smartphones, need for compliance & collab …
- インダストリアルIoT（IIoT）向けデータ収集・デバイス管理プラットフォームの世界市場2018-2022About IIoT Data Collection and Device Management Platform An Industrial Internet of Things (1IoT) platform is a combination of hardware and software facilities, which assists and supports applications for industries, using the Internet to connect devices and equipment. Technavio’s analysts forecast the global IIoT data collection and device management platform market to grow at a CAGR of 15.68% du …
- 世界の自動車内装（Interiors）市場動向（2012-2016）TechNavio’s analysts forecast the Global Automotive Interiors market to reach US$325.12 billion by 2016. One of the key factors contributing to this market growth is the increase in automotive production and sales. The Global Automotive Interiors market has also been witnessing increasing partnerships and alliances. However, the increasing raw material cost could pose a challenge to the growth of …
- フィリピンのマイクロ保険市場2016-2020About Micro-Insurance Products Micro-insurance products are coverage policies targeted at households with low income levels. Micro-insurance plans provide tailored insurance coverage policies for individuals with little or low saving plans. Such policies provide lower value assets and compensation for injury, illness, or death to an individual than in other insurance policies. Micro-insurance comp …
- スパイラル型膜の世界市場予測（～2023年）“The spiral membrane market is projected to grow at a CAGR of 10.0% from 2018 to 2023.” The spiral membrane market is projected to grow from USD 5.10 billion in 2018 to USD 8.20 billion by 2023, at a CAGR of 10.0% from 2018 to 2023. The scarcity of pure water propels the reuse and treatment of wastewater, which attributed to the growth of advanced membrane technologies like Reverse osmosis and nan …
